🧪Trial version — For internal lab review only. Not for clinical or production use.
VaxIQ/HPV Bivalent (Cervarix)
← Back to VaxIQ

HPV Bivalent (Cervarix)

HPV Bivalent Vaccine (Cervarix)

Tier 2 · ExtendedVaccineCuration in progress

Platform: VLP with AS04 adjuvant

Vaccine that protects against HPV types 16 and 18, the two strains responsible for the majority of cervical cancers.

AS04cross-reactiveHPV16/18Cervarixcervical cancer

Immunology Sections

Curated section analysis in progress

Structured immunology sections — mechanism, immune response, molecular signatures, correlates of protection, and more — are being prepared by the Precision Vaccines Program team. In the meantime, verified references and live literature from PubMed, Semantic Scholar, and Wikipedia are available below.

MechanismImmune ResponseMolecular & Immune SignaturesCorrelates of ProtectionOpen QuestionsImmunogenicitySafetyInfection Immunology

Wikipedia Overview

Full article ↗

Cervarix is a vaccine against certain types of cancer-causing human papillomavirus (HPV).

PubMed Literature

Search PubMed ↗

No PubMed results retrieved.

Semantic Scholar

Search S2 ↗

No Semantic Scholar results retrieved.